CVS Health (NYSE:CVS) Announces Earnings Results, Beats Estimates By $0.30 EPS

CVS Health (NYSE:CVS) posted its earnings results on Wednesday. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30, Zacks reports. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health updated its FY 2025 guidance to 5.750-6.000 EPS.

CVS Health Trading Down 0.0 %

Shares of NYSE:CVS traded down $0.00 during trading on Friday, hitting $66.37. 1,601,171 shares of the company’s stock were exchanged, compared to its average volume of 13,128,340. CVS Health has a 1-year low of $43.56 and a 1-year high of $80.75. The firm has a 50-day moving average price of $50.90 and a two-hundred day moving average price of $56.01. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The firm has a market cap of $83.52 billion, a P/E ratio of 16.84, a PEG ratio of 0.60 and a beta of 0.61.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.01%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio is 67.51%.

Analyst Ratings Changes

A number of research firms recently issued reports on CVS. Truist Financial raised their target price on shares of CVS Health from $60.00 to $76.00 and gave the company a “buy” rating in a research note on Thursday. Wolfe Research raised their price target on shares of CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a research report on Tuesday. Barclays raised their price target on shares of CVS Health from $71.00 to $73.00 and gave the stock an “overweight” rating in a research report on Thursday. TD Cowen raised their price target on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Finally, Piper Sandler reduced their price objective on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a report on Monday, November 25th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $70.28.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.